OCT News and Research

RSS

Daschle still making voice heard on health care

The Hill reports that former Senate Majority Leader Tom Daschle helped Obama Administration officials strategize to win health care reform votes from Senators on Capitol Hill Wednesday.

19 Nov 2009

Aegera Therapeutics commences AEG35156 Phase 2B study for AML

Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage development for multiple oncology indications.

19 Nov 2009

Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System

Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.

16 Nov 2009

Lack of health insurance leads to death of 2,266 U.S. military veterans in 2008

A research team at Harvard Medical School estimates 2,266 U.S. military veterans under the age of 65 died last year because they lacked health insurance and thus had reduced access to care. That figure is more than 14 times the number of deaths (155) suffered by U.S. troops in Afghanistan in 2008, and more than twice as many as have died (911 as of Oct. 31) since the war began in 2001.

11 Nov 2009

Prepubertal boys with cancer can bank on their testicular tissue for preserving fertility

For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.

10 Nov 2009

Costly ER bills raise questions, concerns

McClatchy/The Sacramento Bee reports on a the experience of Scott Hawkins, a 23-year old student who received five minutes of ER care at the UC Davis Medical Center before being pronounced dead. McClatchy reports: "Few question the extent to which doctors tried to save the student's life on Oct. 21, but the amount billed for his emergency care has provoked outrage - a further example, critics said, of what is wrong in a health care system that is roundly maligned for its escalating costs."

9 Nov 2009

NHLBI stops enrollment in study comparing resuscitation strategies

Enrollment has ended early in a large, multicenter clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service (EMS) providers to increase blood flow during cardiac arrest. The study's independent monitoring board and the National Heart, Lung, and Blood Institute (NHLBI), the lead sponsor of the study, stopped enrollment based on preliminary data suggesting that neither strategy significantly improved survival.

7 Nov 2009

Health policy research roundup

Health Affairs: Enrollment Is Driving Medicaid Costs—But Two Targets Can Yield Savings - "Although Medicaid spending has grown faster than the rate of increase in national health spending, much of this is explained by increased enrollment," write the authors of this paper, who present data showing that "[p]er enrollee, Medicaid spending actually compares favorably to increases in medical care prices and gross domestic product."

7 Nov 2009

Gonorrhea medication may help fight cancer

Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.

6 Nov 2009

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

The U.S. Department of Health and Human Services (HHS) today announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.

6 Nov 2009

Atrium Medical presents final results of its "COCTAIL study"

Atrium Medical Corporation is proud to announce the release of the final results of the "COCTAIL Study," a clinical study comparing local administration of an anti-platelet medication with the company's proprietary infusion balloon technology.

5 Nov 2009

Case Western Reserve images heart tissue through Avo produced OCT catheters

Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5 million of these cases cannot be treated or controlled through medication alone. Since pharmacological therapies have limited effectiveness, radiofrequency (RF) catheter ablation has emerged as the prominent approach for treating a broad range of arrhythmias.

5 Nov 2009

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

According to the Centers for Disease Control (CDC), H1N1 - better known as the swine flu - was widespread in 48 states as of Oct. 18-24. The CDC's website offers guidelines, from cough etiquette to keeping sick workers at home, for healthcare professionals and the public on how to minimize spread of the H1N1 influenza.

5 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009

Lovastatin-synthesizing enzyme successfully reconstituted

Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have for the first time successfully reconstituted in the laboratory the enzyme responsible for producing the blockbuster cholesterol-lowering drug lovastatin.

4 Nov 2009

Blood vessels good indicators of prostate cancer behavior

A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed?

4 Nov 2009

Reid: Lawmakers may not complete health legislation this year

CongressDaily: "Senate Majority Leader Reid is not expected to receive until next week scoring from CBO that will allow him to piece together a final healthcare overhaul bill, Senate sources said today. The possible two-week review period on proposals that Reid sent CBO Oct. 26 has bolstered speculation that an overhaul bill might not come to the Senate floor before December in a debate that could stretch into next year."

3 Nov 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.

3 Nov 2009

Swine flu vaccine supply expected to increase 'in short order'

A senior adviser to President Barack Obama says the government "overpromised" with the swine flu vaccine but that the vaccine supply would catch up with the demand within a week. Meanwhile, a health group established to monitor the vaccine's safety will begin work this week.

3 Nov 2009

Heart, cancer doctors get break on scheduled Medicare pay cuts

Heart and cancer doctors will get a smaller fee cut next year from Medicare, the U.S. government program for the elderly, than the Obama administration first sought in a move to shift money to family physicians," Bloomberg reports. Earlier this year, Medicare officials said they would cut 10 percent of payments for the two specialties. Now, they plan on making the reductions over four years, instead.

2 Nov 2009